185 related articles for article (PubMed ID: 19259319)
1. Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status.
Gunderson LL; Callister M; Marschke R; Young-Fadok T; Heppell J; Efron J
Gastrointest Cancer Res; 2008 Jan; 2(1):25-33. PubMed ID: 19259319
[TBL] [Abstract][Full Text] [Related]
2. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.
Gunderson LL; Sargent DJ; Tepper JE; O'Connell MJ; Allmer C; Smalley SR; Martenson JA; Haller DG; Mayer RJ; Rich TA; Ajani JA; Macdonald JS; Goldberg RM
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):386-96. PubMed ID: 12243812
[TBL] [Abstract][Full Text] [Related]
3. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Gunderson LL; Sargent DJ; Tepper JE; Wolmark N; O'Connell MJ; Begovic M; Allmer C; Colangelo L; Smalley SR; Haller DG; Martenson JA; Mayer RJ; Rich TA; Ajani JA; MacDonald JS; Willett CG; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1785-96. PubMed ID: 15067027
[TBL] [Abstract][Full Text] [Related]
4. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes.
Gunderson LL; Jessup JM; Sargent DJ; Greene FL; Stewart A
J Clin Oncol; 2010 Jan; 28(2):256-63. PubMed ID: 19949015
[TBL] [Abstract][Full Text] [Related]
5. Revised TN categorization for colon cancer based on national survival outcomes data.
Gunderson LL; Jessup JM; Sargent DJ; Greene FL; Stewart AK
J Clin Oncol; 2010 Jan; 28(2):264-71. PubMed ID: 19949014
[TBL] [Abstract][Full Text] [Related]
6. Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment.
Gunderson LL; Haddock MG; Schild SE
Semin Radiat Oncol; 2003 Oct; 13(4):419-32. PubMed ID: 14586831
[TBL] [Abstract][Full Text] [Related]
7. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer.
Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG
Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501
[TBL] [Abstract][Full Text] [Related]
8. Staging Paradox and Discrepancy in Adjuvant Chemotherapy in Patients with T4N0, T1-2N1, and T3N1 Colon Cancer.
Shimizu H; Kuriu Y; Arita T; Kiuchi J; Yamamoto Y; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
World J Surg; 2021 May; 45(5):1561-1568. PubMed ID: 33538878
[TBL] [Abstract][Full Text] [Related]
9. Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.
Gunderson LL; Moughan J; Ajani JA; Pedersen JE; Winter KA; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett CG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):638-45. PubMed ID: 24035327
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis.
Xu AA; Miao JJ; Wang L; Li AC; Han F; Shao XF; Mo ZW; Huang SM; Yuan YW; Deng XW; Zhao C
Radiat Oncol; 2023 Apr; 18(1):63. PubMed ID: 37020312
[TBL] [Abstract][Full Text] [Related]
11. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
12. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II-III resectable rectal cancer: 5-Year survival data of a randomized controlled trial.
Kairevičė L; Latkauskas T; Tamelis A; Petrauskas A; Paužas H; Žvirblis T; Jaruševičius L; Saladžinskas Ž; Pavalkis D; Jančiauskienė R
Medicina (Kaunas); 2017; 53(3):150-158. PubMed ID: 28690144
[TBL] [Abstract][Full Text] [Related]
13. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer.
Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482
[TBL] [Abstract][Full Text] [Related]
14. Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy.
Dawson LA; Franssen E; Davey P
Cancer J Sci Am; 1999; 5(6):374-9. PubMed ID: 10606480
[TBL] [Abstract][Full Text] [Related]
15. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
16. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
[TBL] [Abstract][Full Text] [Related]
17. Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases.
Chen FP; Lin L; Liang JH; Tan SH; Ong EHW; Luo YS; Huang L; Sim AYL; Wang HT; Gao TS; Deng B; Zhou GQ; Kou J; Chua MLK; Sun Y
Ther Adv Med Oncol; 2021; 13():17588359211052417. PubMed ID: 34721672
[TBL] [Abstract][Full Text] [Related]
18. Recurrence risk and prognostic parameters in stage I rectal cancers.
Cihan S; Kucukoner M; Ozdemir N; Dane F; Sendur MA; Yazilitas D; Urakci Z; Durnali A; Yuksel S; Aksoy S; Colak D; Seker MM; Taskoylu BY; Oguz A; Isikdogan A; Zengin N
Asian Pac J Cancer Prev; 2014; 15(13):5337-41. PubMed ID: 25040998
[TBL] [Abstract][Full Text] [Related]
19. Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.
Lee JH; Yu M; Kim SH; Lee JH; Sung SY; Jeong BK; Jeong S; Nam TK; Jeong JU; Jang HS
Clin Colorectal Cancer; 2019 Mar; 18(1):e130-e139. PubMed ID: 30595556
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
Mayadev J; Elshaikh MA; Christie A; Nagel C; Kennedy V; Khan N; Lea J; Ghanem A; Miller D; Xie XJ; Folkert M; Albuquerque K
Am J Clin Oncol; 2018 Dec; 41(12):1220-1224. PubMed ID: 29683799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
